Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
2018 · Journal of the American College of Cardiology · 1,482 citations
https://doi.org/10.1016/j.jacc.2018.02.037
K
Kerry L. Reynolds
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
333
Papers
13.9K
Citations
54
h-index
131
i10-index
Kerry L. Reynolds is an academic researcher from Massachusetts Mental Health Center. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Colorectal Cancer Treatments and Studies & CAR-T cell therapy research. The author has an h-index of 54, co-authored 284 publications.
ORCID: 0000-0002-7793-654XPapers by this author
worksAssociation Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque
2020 · Circulation · 507 citations
https://doi.org/10.1161/circulationaha.120.049981
Clinical Features and Outcomes of Immune Checkpoint Inhibitor–Associated AKI: A Multicenter Study
2020 · Journal of the American Society of Nephrology · 376 citations
https://doi.org/10.1681/asn.2019070676
The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors
2019 · Clinical Journal of the American Society of Nephrology · 293 citations
https://doi.org/10.2215/cjn.00990119
Acute kidney injury in patients treated with immune checkpoint inhibitors
2021 · Journal for ImmunoTherapy of Cancer · 217 citations
https://doi.org/10.1136/jitc-2021-003467
Diagnosis and Management of Hepatitis in Patients on Checkpoint Blockade
2018 · The Oncologist · 102 citations
https://doi.org/10.1634/theoncologist.2018-0174
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat